Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.04%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 2.75Close
$ 0.73 - $ 3.83 52-Week Range
Ticker Information
Ticker
ESPRCompany Name
ESPERION THERAPEUTICS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQESPERION THERAPEUTICS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ESPR - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 106K | 0.04% | $ 268.13M |
| 3/31/2025 | $ 89K | 0.03% | $ 259.57M |
| 12/31/2024 | $ 63K | 0.02% | $ 332.31M |
| 9/30/2024 | $ 42K | 0.01% | $ 295.45M |
| 6/30/2024 | $ 42K | 0.02% | $ 277.79M |
| 3/31/2024 | $ 83K | 0.04% | $ 229.74M |
| 12/31/2023 | $ 164K | 0.14% | $ 116.33M |
| 9/30/2023 | $ 250K | 0.24% | $ 102.9M |
| 6/30/2023 | $ 329K | 0.37% | $ 87.91M |
| 3/31/2023 | $ 428K | 0.53% | $ 80.97M |
Key Performance Insights, Last 5 Years
- ESPERION THERAPEUTICS INC's latest trailing twelve months (TTM) DepAmor % stands at 0.22%.
- Over the past 5 years, ESPERION THERAPEUTICS INC's average DepAmor % has been 0.39%.
- The median DepAmor % for ESPERION THERAPEUTICS INC during this period was 0.25%
- ESPERION THERAPEUTICS INC reached its highest DepAmor % over the past 5 years at 1.01%.
- The lowest DepAmor % recorded by ESPERION THERAPEUTICS INC in the same timeframe 0.01%
ESPERION THERAPEUTICS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for ESPERION THERAPEUTICS INC is calculated as follows: DepAmor [ $ 488K ] / Revenues [ $ 218.89M ]
(=) DepAmor % [ 0.22% ] ESPR - Depreciation and Amortization Margin, Last 5 years
0.01%
Minimum
Sep 30, 2024
1.01%
Maximum
Jun 30, 2021
0.39%
Average
0.25%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.13%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.32K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.2% |
| std | 5.13% |